Literature DB >> 12612904

A quantitative gene expression study suggests a role for angiopoietins in focal nodular hyperplasia.

Valérie Paradis1, Ivan Bièche, Delphine Dargère, Ingrid Laurendeau, Juliette Nectoux, Claude Degott, Jacques Belghiti, Michel Vidaud, Pierre Bedossa.   

Abstract

BACKGROUND AND AIMS: Although the pathogenesis of focal nodular hyperplasia (FNH) of the liver remains unclear, a vascular mechanism has been suspected. To gain insight into the pathogenesis of FNH, we performed a large-scale quantitative study of gene expression in FNH.
METHODS: Quantitative expression level of 209 selected genes was assessed using real-time reverse-transcription polymerase chain reaction in 14 cases of FNH and compared with their expression level in 13 cases of liver cirrhosis, 4 adenomas, and 15 hepatocellular carcinomas.
RESULTS: Among the 7 genes, the expression of which was significantly up-regulated or down-regulated in FNH, the most informative markers for the diagnosis of FNH as assessed using the receiving operative curve and area under the curve (AUC) were angiopoietin-1 (Ang-1; AUC, 0.82) and angiopoietin-2 (Ang-2; AUC, 0.80). These 2 genes are involved in the regulation of vasculogenesis. In FNH, Ang-1 was significantly up-regulated, Ang-2 was down-regulated, and the Ang-1/Ang-2 ratio was highly and specifically increased in FNH compared with normal liver or other groups of lesions (FNH, 15.2-fold increase; HCC, 2.78; adenoma, 2.28; cirrhosis, 1.92; P < 0.01 for FNH vs. all groups, analysis of variance). Tie-2 messenger RNA, the receptor of Ang-1 and Ang-2, was detected at the same level in FNH as in normal liver. Ang-1 protein was detected on Western blot of FNH and expressed by endothelial cells of dystrophic vessels and sinusoids as shown by immunohistochemistry.
CONCLUSIONS: A specific increase of Ang-1/Ang-2 ratio in FNH, in the presence of the functional Tie-2 receptor, might be involved in the formation of hyperplastic and dystrophic vessels of FNH.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12612904     DOI: 10.1053/gast.2003.50104

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  15 in total

Review 1.  Hepatocellular nodules in vascular liver diseases.

Authors:  Christine Sempoux; Charles Balabaud; Valérie Paradis; Paulette Bioulac-Sage
Journal:  Virchows Arch       Date:  2018-05-26       Impact factor: 4.064

2.  Quantitative gene expression in Budd-Chiari syndrome: a molecular approach to the pathogenesis of the disease.

Authors:  V Paradis; I Bièche; D Dargère; D Cazals-Hatem; I Laurendeau; V Saada; J Belghiti; A Bezeaud; M Vidaud; P Bedossa; D-C Valla
Journal:  Gut       Date:  2005-09-14       Impact factor: 23.059

3.  Senescence markers in focal nodular hyperplasia of the liver: pathogenic considerations on the basis of immunohistochemical results.

Authors:  Helmut Denk; Daniela Pabst; Peter M Abuja; Robert Reihs; Brigitte Tessaro; Kurt Zatloukal; Carolin Lackner
Journal:  Mod Pathol       Date:  2021-10-13       Impact factor: 7.842

4.  Angiopoietin-1 causes reversible degradation of the portal microcirculation in mice: implications for treatment of liver disease.

Authors:  Nicole L Ward; Alexandra L Haninec; Paul Van Slyke; John G Sled; Celina Sturk; R Mark Henkelman; Ian R Wanless; Daniel J Dumont
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

5.  Focal nodular hyperplasia of the liver: an unusual association with diabetes mellitus in a child and review of literature.

Authors:  Piero Farruggia; Rita Alaggio; Francesca Cardella; Serena Tropia; Antonino Trizzino; Francesca Ferrara; Paolo D'Angelo
Journal:  Ital J Pediatr       Date:  2010-05-26       Impact factor: 2.638

6.  Clonality and allelotype analyses of focal nodular hyperplasia compared with hepatocellular adenoma and carcinoma.

Authors:  Yi-Ran Cai; Li Gong; Xiao-Ying Teng; Hong-Tu Zhang; Cheng-Feng Wang; Guo-Lian Wei; Lei Guo; Fang Ding; Zhi-Hua Liu; Qin-Jing Pan; Qin Su
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

7.  Molecular profiling of hepatocellular carcinomas (HCC) using a large-scale real-time RT-PCR approach: determination of a molecular diagnostic index.

Authors:  Valérie Paradis; Ivan Bièche; Delphine Dargère; Ingrid Laurendeau; Christophe Laurent; Paulette Bioulac Sage; Claude Degott; Jacques Belghiti; Michel Vidaud; Pierre Bedossa
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

8.  Focal nodular hyperplasia with major sinusoidal dilatation: a misleading entity.

Authors:  Hervé Laumonier; Nora Frulio; Christophe Laurent; Charles Balabaud; Jessica Zucman-Rossi; Paulette Bioulac-Sage
Journal:  BMJ Case Rep       Date:  2010-12-01

9.  How normal is the liver in which the inflammatory type hepatocellular adenoma develops?

Authors:  Jing Han; Marius C van den Heuvel; Hironori Kusano; Koert P de Jong; Annette S H Gouw
Journal:  Int J Hepatol       Date:  2012-09-17

10.  Angiopoietin-2 Serum Levels Improve Noninvasive Fibrosis Staging in Chronic Hepatitis C: A Fibrogenic-Angiogenic Link.

Authors:  Angel Hernández-Bartolomé; Rosario López-Rodríguez; Yolanda Rodríguez-Muñoz; Samuel Martín-Vílchez; María Jesús Borque; Luisa García-Buey; Leticia González-Moreno; Yolanda Real; Ricardo Moreno-Otero; Paloma Sanz-Cameno
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.